Advanced approach for target small rnas enrichment from biological samples and sequencing library preparation (TSR-SEQ) - cell-free rnas (cfrna) are emerging as a novel class of diagnostic,…

Active Project Grant Awarded Last action

Award ID
R43CA314894
Recipient
Awarding agency
Obligated
$1

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date 13% complete
Funding agency
National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
Place of performance
Santa Cruz, CA, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Advanced approach for target small rnas enrichment from biological samples and sequencing library preparation (TSR-SEQ) - cell-free rnas (cfrna) are emerging as a novel class of diagnostic, prognostic, and predictive cancer biomarkers that provide higher sensitivity because RNA is transcribed in multiple copies from genomic DNA templates. Furthermore, dramatic changes in the RNA expression in tumors, dysregulated RNA post- transcriptional events, and formation of chimeric rnas that are detectable only in the transcriptome contribute to the higher potential of the cfrna as cancer biomarkers. Most cfrna molecules (~95%) found in human plasma are srnas of…

Quick answers

Who received award R43CA314894?

R43CA314894 was awarded to Realseq Biosciences, Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2026.

How much is award R43CA314894 worth?

$1 has been obligated on R43CA314894.

Which agency awarded R43CA314894?

National Cancer Institute (National Institutes of Health) awarded R43CA314894, with funding from National Human Genome Research Institute (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login